Treatment of metachronous and simultaneous liver metastases of pancreatic cancer.

Dünschede, F; Will, L; von Langsdorf, C; Möhler, M; Galle, P R; Otto, G; Vahl, C F; Junginger, T

Dünschede, F; Will, L; von Langsdorf, C; Möhler, M; Galle, P R; Otto, G; Vahl, C F; Junginger, T.

Affiliation

Dünschede F; Department of Cardiothoracic and Vascular Surgery, Johannes Gutenberg University Hospital, Mainz, Germany. Duenschede @ htg.klinik.uni-mainz.de

Eur Surg Res ; 44(3-4): 209-13, 2010.

Article in En | MEDLINE | ID: mdl-20571276

Subject(s)

Liver Neoplasms/secondary; Liver Neoplasms/therapy; Pancreatic Neoplasms/therapy; Adult; Aged; Antimetabolites, Antineoplastic/therapeutic use; Deoxycytidine/analogs & derivatives; Deoxycytidine/therapeutic use; Female; Hepatectomy; Humans; Kaplan-Meier Estimate; Liver Neoplasms/drug therapy; Liver Neoplasms/surgery; Male; Middle Aged; Pancreatic Neoplasms/drug therapy; Pancreatic Neoplasms/surgery; Retrospective Studies; Time Factors; Gemcitabine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Liver Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Surg Res Year: 2010 Document type: Article Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google